Our Leaders > Jeffrey Kranzel

Jeffrey Kranzel

Managing Director

As a Managing Director in the New York office, Jeff is responsible for client service, specializing in accounting change and technical accounting issues.

At Riveron, we deliver the expertise of a traditional firm with an agility unlike any other. We work side by side with our clients to meet their business objectives.
Globetrotter. Urban dweller. Cocktail aficionado.


Jeff brings a wealth of industry and public accounting experience advising financial services clients on new accounting standard implementations, GAAP conversions, deal structuring, and other transaction accounting matters.

Prior to joining Riveron, Jeff was the Head of Accounting Policy for Mizuho Americas.  In this role, Jeff led a team of finance professionals to implement new accounting standards, liaise with the auditors, and advise the front office and financial reporting on the accounting for new products and structures. Before Mizuho, Jeff was a Director in KPMG’s Accounting Advisory Services in New York and completed a three year rotation in London advising on IFRS.

Jeff is a subject matter resource on accounting change and technical accounting issues related to revenue recognition, leasing, consolidation, financial instruments, transfers of financial assets, and more.

Education and Certifications

  • Bachelor of Science in Accounting, Pennsylvania State University
  • Bachelor of Science in Spanish, Pennsylvania State University
  • Certified Public Accountant

Related Insights

Accounting for Internal-Use Software: A Practical Application

Two key things for companies to consider as they determine whether the costs for internal use software development should be capitalized or expensed.

No Material Impact to Disclose with CECL? Prove It!

As companies turn their attention to CECL, the new credit loss guidance, they are required by SEC to disclose the potential impact of the new standard, even if it’s immaterial.

Diagnosing the Accounting in Complex Healthcare Arrangements

Three considerations for hospitals, healthtech companies, and industry providers when evaluating the accounting and financial reporting implications of new arrangements.